VEGFR3/Flt-4 Antibody (AFL4) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # NBP1-43502
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Mouse
Applications
Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Rat IgG2a Kappa Clone # AFL4
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Product Summary for VEGFR3/Flt-4 Antibody (AFL4) [Biotin]
Immunogen
The immunogen for this antibody was VEGFR3.
Reactivity Notes
This antibody is reactive to Mouse.
Clonality
Monoclonal
Host
Rat
Isotype
IgG2a Kappa
Applications for VEGFR3/Flt-4 Antibody (AFL4) [Biotin]
Application
Recommended Usage
Flow Cytometry
1:10-1:1000
Application Notes
The AFL4 antibody has been tested by flow cytometric analysis of in vitro differentiated mouse endothelial cells. In brief, mouse ES cells were incubated on collagen IV matrix for 4 days and subsequently stimulated with VEGF under serum free conditions to induce further differentiation.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
PBS (pH 7.2) with 0.1% gelatin
Preservative
0.09% Sodium Azide
Concentration
Concentrations vary lot to lot. See vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: VEGFR3/Flt-4
Long Name
Vascular Endothelial Growth Factor Receptor 3
Alternate Names
Flt-4, FLT4, VEGF R3
Gene Symbol
FLT4
Additional VEGFR3/Flt-4 Products
Product Documents for VEGFR3/Flt-4 Antibody (AFL4) [Biotin]
Product Specific Notices for VEGFR3/Flt-4 Antibody (AFL4) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...